Loading
Latest filing published 23 Oct 2023 for RVL Pharmaceuticals plc, €140k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Altchem Ltd on record concern RVL Pharmaceuticals plc. The record holds 4 filings, for trades running from 13 January 2020 to 20 October 2023.
The open-market side counts 1 purchase for €5.6M alongside 3 sales for €758k. Purchases outweigh sales by €4.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2023 to date brings no purchases and 3 sales.
Most recently, on 23 October 2023, the filings show an open-market sale worth €140k in RVL Pharmaceuticals plc. The last purchase on record was published on 15 January 2020, which is 2,474 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Avista Capital Partners III GP, L.P., counted once
4 of 1 declaration